Atlas Trials

Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

Clinical trial NCT03092765 · TERMINATED

Trial details

NCT number
NCT03092765
Sponsor
EA Pharma Co., Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Biliary Cholangitis
Start date
2017-05-29
Primary completion
2018-08-27
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.